📲 JOIN THE OPTILAB ENGINE → https://whop.com/the-optimization-lab/the-optilab-engine/ ⚠️ DISCLAIMER: This content is for educational and informational purposes only and is not medical advice, diagnosis, treatment, or a recommendation to use any compound. Any compounds discussed may be investigational, and their safety, efficacy, appropriate dosing, long-term effects, contraindications, and drug interactions may not be established. Discussion of mechanism, preclinical or published research, or potential applications should not be interpreted as evidence of proven benefit in humans. Do not purchase, administer, use, or investigate any compound based on social media content. Always discuss health, performance, medications, supplements, or experimental therapies with a qualified healthcare professional. 🎓 ABOUT THIS VIDEO This episode breaks down peptides, hormone optimization, and why outcomes depend far more on context than on the compound alone. Nathan and Dr. Gabriel Alizaidy dig into how peptide use should be assessed, covering compounds like MOTS-c, CJC-1295, and ipamorelin, GLP-1s, growth hormone, and thyroid and testosterone markers like SHBG, and why blood work is only one piece of the puzzle. Dr. Alazeti brings both clinical and research experience, plus a practical anti-hype approach shaped by years of working in peptide and hormone optimization. The conversation also covers regulatory realities, why some compounds become mainstream while others stay stuck in gray areas, and how providers can do better by asking more questions, not fewer. 🏋️♂️ WORK WITH ME Apply for coaching → https://theoptimizationlab.cc/bio 📘 FREE RESOURCES Mitochondrial Enhancement Blueprint → https://theoptimizationlab.cc/bio Pillars of Fat Loss → https://drive.google.com/file/d/13mtEyUY7WDu2ONRfq-bKwWHP_gjMh4Zs/view Elbow Tendinopathy → https://drive.google.com/file/d/1eHboUOYedtomxHy2MMyKWcHmAqa1F6Yk/view 💪 FOLLOW ME Instagram: https://instagram.com/optimalnathan 🧠 TIMESTAMPS 00:00 - Nathan frames the episode around peptides, mitochondria, growth hormone, recovery compounds, and regulatory change 00:57 - Dr. Gabriel Alizaidy is introduced as a physician, clinical researcher, and scientific director at Maximus 03:25 - Why peptides get oversold online and why the evidence base often lags behind the hype 05:13 - Gabriel's background in bodybuilding, longevity, and how his view of peptides evolved over time 06:45 - Why educational content gets flattened into one-line claims and why that causes problems 09:23 - How Nathan and Gabriel both see the effects and limits of MOTS-c in real life 11:38 - Why context matters more than a protocol, using testosterone, estrogen, and bodybuilding as examples 12:36 - Nathan's thyroid and autoimmune example to illustrate environment-specific responses 16:18 - Gabriel explains why peptide use should start with a full conversation, not a shopping list 17:14 - Why a deep intake matters more than chasing a number on paper 21:24 - What Gabriel's intake actually covers, including sleep, diet, social life, and goals 24:11 - Why explaining the reasoning out loud can improve both the provider's thinking and the patient's understanding 25:57 - Why most people need better foundations before peptides are added 27:29 - Why Nathan and Gabriel often talk people down from adding more compounds 28:08 - T3, mitochondria, and why people sometimes ignore the real upstream driver 30:09 - Why 70-compound protocols become a polypharmacy nightmare 31:37 - Gabriel's three core priorities: GLP-1s, growth hormone, and hormone optimization 32:52 - Why basic supplements can outperform complex protocols when used correctly 36:01 - How simple timing changes can dramatically improve sleep and response 40:21 - Why CJC-1295 and ipamorelin are not as simple as the hype suggests 43:05 - Why receptor desensitization and conversion steps matter in secretagogue use 46:55 - When Gabriel still sees a place for secretagogues, especially in telemedicine constraints 49:10 - Why IGF-1 and hormone markers are proxies, not the full story 53:11 - Why chasing a lab number without symptoms and context can lead people astray 55:06 - Why telemedicine needs more touchpoints, more aggregation, and more human involvement 57:11 - Gabriel's AI-assisted, adaptive intake concept that asks more questions as it learns more 1:03:34 - Why humility and saying "I don't know" are part of being credible in a fast-moving field 1:07:34 - Nathan revisits a correction on thyroid transport and why he updates his material when data changes 1:16:23 - Gabriel shares an evolving view on SHBG, free testosterone, and megalin-related transport 1:20:24 - Why peptides are not simply ignored because of a conspiracy, but because of patent, regulation, and indication barriers 1:23:26 - Why FDA approval takes years, costs a lot, and requires a clear indication
